Note: Ingredients listed on restricted chemical lists
EC/CAS
270-325-2/68424-85-1
Name of the chemical
Alkyl (C12-16) dimethylbenzyl ammonium chloride
Concentration
1 - 5
EC/CAS
230-525-2/7173-51-5
Name of the chemical
Didecyldimethylammonium chloride
Concentration
1 - 5
General Information
Version
10.5
Revision date
2023-05-12
Product name
SELGIENE ULTRA (VMIX)
1.2.1 Relevant identified uses
Professional use
Emergency telephone
+31 (0) 43 363 42 89, +353 1 809 2566, +353 1 809 2166, 0344 892 0111
Icons in SDS
Company Information
company name
SELDEN RESEARCH LIMITED
e-mail address of the competent person responsible for the Safety Data Sheet
sds@selden.eu, safety@selden.co.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318, H400, H410, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
Adverse physicochemical, human health and environmental effects
Causes severe skin burns and eye damage. Very toxic to aquatic life. Toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS09
Signal word
Danger
Contains
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides, didecyldimethylammonium chloride
Hazard statements
H315 - Causes skin irritation. H318 - Causes serious eye damage. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P264 - Wash hands thoroughly after handling. P273 - Avoid release to the environment. P280 - Wear eye protection, protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P315 - Get immediate medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P391 - Collect spillage.
2.3 Other hazards
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
